Indacaterol: all 84 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Role of Lung Function for Exercise Capacity in Well-trained IndividualsRecruitingNCT06077019Not applicable
• Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.CompletedNCT03257995Phase 2Results posted
• Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With AsthmaCompletedNCT02892344Phase 3Results posted
• Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With AsthmaCompletedNCT02892019Phase 2Results posted
• RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials CooperativeCompletedNCT02867761Phase 3Results posted
• A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With AsthmaCompletedNCT02554786Phase 3Results posted
• Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of ExacerbationsCompletedNCT02418468Phase 4Results posted
• Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)CompletedNCT02202616Phase 4Results posted
• Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPDCompletedNCT02055352Phase 4Results posted
• Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenCompletedNCT01985334Phase 4Results posted
• Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent AsthmaCompletedNCT01959412Phase 2Results posted
• A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting BronchodilatorCompletedNCT01794780Phase 4Results posted
• Indacaterol EfectIveness In COPD Patients With Tuberculosis HistoryCompletedNCT01778062Phase 3Results posted
• Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD PatientsCompletedNCT01727024Phase 4Results posted
• Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent AsthmaCompletedNCT01609478Phase 2Results posted
• Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)CompletedNCT01555138Phase 4Results posted
• Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01543828Phase 4Results posted
• A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 DeviceCompletedNCT01484197Phase 2Results posted
• 12-week Open-label Evaluation of Efficacy and Safety of IndacaterolCompletedNCT01232894Phase 3Results posted
• Efficacy, Safety and Pharmacokinetics of Different Regimens of IndacaterolCompletedNCT01156844Phase 2Results posted
• Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01089127Phase 3Results posted
• Efficacy and Safety of Different Doses of IndacaterolCompletedNCT01079130Phase 3Results posted
• 12-week Efficacy of IndacaterolCompletedNCT01072448Phase 3Results posted
• Comparison of Efficacy of Indacaterol Versus Placebo Over 12 WeeksCompletedNCT01068600Phase 3Results posted
• Effect of Indacaterol on Inspiratory Capacity (IC)CompletedNCT01012765Phase 3Results posted
• Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon DevicesCompletedNCT01012739Phase 2Results posted
• Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory CapacityCompletedNCT00999908Phase 3Results posted
• Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With AsthmaCompletedNCT00927901Phase 2Results posted
• A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00900731Phase 3Results posted
• Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00877383Phase 3Results posted
• Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00876694Phase 3Results posted
• Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00846586Phase 3Results posted
• Exacerbation StudyCompletedNCT00845728Phase 3Results posted
• Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00821093Phase 3Results posted
• Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00794157Phase 3Results posted
• Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00792805Phase 3Results posted
• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00677807Phase 3Results posted
• Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00669617Phase 3Results posted
• An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)CompletedNCT00636961Phase 2Results posted
• Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00624286Phase 3Results posted
• A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00622635Phase 3Results posted
• The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT00620022Phase 3Results posted
• Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate AsthmaCompletedNCT00605306Phase 2Results posted
• Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00570778Phase 2Results posted
• Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active ControlCompletedNCT00567996Phase 3Results posted
• Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00558285Phase 2Results posted
• A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via the TWISTHALER® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00557466Phase 2Results posted
• Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent AsthmaCompletedNCT00557440Phase 2Results posted
• Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With AsthmaCompletedNCT00556673Phase 2Results posted
• A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent AsthmaCompletedNCT00545272Phase 2Results posted
• Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and SalmeterolCompletedNCT00531050Phase 2Results posted
• Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent AsthmaCompletedNCT00529529Phase 3Results posted
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00463567Phase 2/3Results posted
• Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00403845Phase 2Results posted
• Dose Ranging Study for Indacaterol in Japanese Asthma PatientsCompletedNCT00403754Phase 2Results posted
• Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active ControlCompletedNCT00393458Phase 3Results posted
• Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPDSuspendedNCT07541378Not applicable
• Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass ExposureCompletedNCT05506865Phase 4
• Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference ProductCompletedNCT05288075Phase 1
• Utilizing Wearable Device to Observe the Clinical Response of COPD Patients Treated With Combined Bronchodilator and Home-based Pulmonary Rehabilitation ProgramStatus unknownNCT03364829Phase 4
• Effect of a LAMA and a uLABA on the Methacholine Dose-response CurveCompletedNCT02953041Phase 4
• Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02872090Phase 4
• A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated EosinophilsTerminatedNCT02693769Phase 2/3
• Indacaterol in Heart Failure Patients: Any Role on Lung Fluid RegulationCompletedNCT02598505Phase 3
• Pulmonary Gas Exchange Response to Indacaterol in COPDStatus unknownNCT02547558Phase 4
• Efficacy in Walked Distance of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass (EMERALD)CompletedNCT02473237Phase 4
• Ultra-long Acting Bronchodilator Therapy in AsthmaticsCompletedNCT02039011Phase 4
• Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD PatientsCompletedNCT01996124Phase 4
• A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test FixtureWithdrawnNCT01845623Phase 2
• Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active ControlWithdrawnNCT01715311Phase 4
• Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPDCompletedNCT01693003Phase 4
• Closing Volume Interpretation and Bronchodilators EffectCompletedNCT01437748Phase 4
• Efficacy of Indacaterol 150 µg Versus FormoterolWithdrawnNCT01377428Phase 4
• Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related DyspneaCompletedNCT01377051Phase 4
• To Determine the Relationship Between Baseline Reversibility and the Efficacy of IndacaterolCompletedNCT01272362Phase 4
• Cardiac Safety of IndacaterolCompletedNCT01263808Phase 1
• Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent AsthmaCompletedNCT00624702Phase 1
• Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and FormoterolCompletedNCT00422552Phase 1/2
• Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver FunctionCompletedNCT00416702Phase 1
• Evaluation of Pharmacokinetic Interaction of Indacaterol With Ketoconazole in Healthy Adult SubjectsCompletedNCT00410501Phase 1
• Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent AsthmaCompletedNCT00403637Phase 2/3
• Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00396604Phase 2/3
• Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00129831Phase 2
• Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00098228Phase 2

← Indacaterol overview